These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


94 related items for PubMed ID: 1331597

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H, Hu SX, Fujino M, Harada M, Kinoshita I, Xu HJ, Kuzumaki N, Kawakami Y, Benedict WF.
    Cancer; 1997 Apr 01; 79(7):1329-37. PubMed ID: 9083154
    [Abstract] [Full Text] [Related]

  • 4. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M, Mattern J.
    Anticancer Res; 1993 Apr 01; 13(6A):2021-5. PubMed ID: 8297109
    [Abstract] [Full Text] [Related]

  • 5. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
    Spandidos DA, Zakinthinos S, Petraki C, Sotsiou F, Yiagnisis M, Dimopoulos AM, Roussos C, Field JK.
    Anticancer Res; 1990 Apr 01; 10(5A):1105-14. PubMed ID: 2173469
    [Abstract] [Full Text] [Related]

  • 6. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
    Nakada K, Fujioka T, Kitagawa H, Takakuwa T, Yamate N.
    Jpn J Clin Oncol; 1993 Jun 01; 23(3):149-55. PubMed ID: 8350488
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
    Mizukami Y, Nonomura A, Noguchi M, Taniya T, Koyasaki N, Saito Y, Hashimoto T, Matsubara F, Yanaihara N.
    Anticancer Res; 1991 Jun 01; 11(4):1485-94. PubMed ID: 1660689
    [Abstract] [Full Text] [Related]

  • 8. Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer.
    Minna JD, Battey JF, Birrer M, Brooks BJ, Cuttitta F, DeGreve J, Gazdar AF, Johnson BE, Nau MM, Sausville EA.
    Princess Takamatsu Symp; 1986 Jun 01; 17():109-22. PubMed ID: 3332004
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.
    Volm M, Efferth T, Mattern J.
    Anticancer Res; 1992 Jun 01; 12(1):11-20. PubMed ID: 1348920
    [Abstract] [Full Text] [Related]

  • 12. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K, Ishida H, Furukawa T, Koyanagi K, Miyamoto Y.
    Rinsho Byori; 1996 Jan 01; 44(1):32-41. PubMed ID: 8691638
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F, Dosaka-Akita H, Mishina T, Nishi M, Kojima T, Hiroumi H, Ogura S, Shimizu M, Katoh H, Kawakami Y.
    Clin Cancer Res; 2000 Oct 01; 6(10):4073-81. PubMed ID: 11051259
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis.
    Vora HH, Shah NG, Patel DD, Trivedi TI, Chikhlikar PR.
    J Surg Oncol; 2003 Jan 01; 82(1):34-50. PubMed ID: 12501167
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of p53 and ras p21 protein expression in surgically treated non-small cell lung carcinoma.
    Cohen R, Guber A, Koren R, Marom Z, Siegal A.
    Rom J Morphol Embryol; 1998 Jan 01; 44(1-4):117-23. PubMed ID: 15678852
    [Abstract] [Full Text] [Related]

  • 16. Immunocytochemical study of RAS oncoprotein in cytologic specimens of primary lung tumours.
    Koutselini H, Kappatou G, Yiagnisis M, Field JK, Spandidos DA.
    Anticancer Res; 1990 Jan 01; 10(3):597-603. PubMed ID: 2164347
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.